UnitedHealth Group Inc
DUS:UNH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
UnitedHealth Group Inc (UNH) under the Base Case is 441.86 EUR per share.
Compared with the current market price of 312.6 EUR, the stock appears
Undervalued by 29% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What UnitedHealth Does
UnitedHealth Group is a healthcare company with two main businesses: health insurance and healthcare services. Through UnitedHealthcare, it sells insurance plans to employers, individuals, and government programs. Through Optum, it also runs businesses that help deliver care, manage prescription benefits, process claims, and support doctors and health systems with data and technology.
- Headquarters
- United States of America US
- Employees
- 390 000
- IPO date
- Oct 17, 1984
UnitedHealth has a narrow economic moat
Buying medical care and medicines for a large customer base gives UnitedHealth bargaining power that smaller competitors struggle to match. Optum’s role in hospitals’ billing and claims processes also makes replacing its services costly and disruptive, helping retain customers even when rivals offer lower prices.
Read the full moat analysisBalance Sheet
Recent Events
Latest Earnings Call
UnitedHealth sees improving execution supporting 2027 growth, while elevated medical costs and continued modernization investments temper the recovery.
Open the earnings call- EPS
- $4.69
- Expected
- $4.12
- Surprise
- +13.8%
- Stock, day of the call
- −0.2%
UnitedHealth insiders are selling within their usual range
Past 12 months
Continue UNH Research
Decided on UnitedHealth? Get an email when UNH reaches the price you’d buy at. Free with an account.
Other UnitedHealth listings
What is the Intrinsic Value of one UNH stock?
The intrinsic value for
UnitedHealth Group Inc (UNH) under the Base Case is 441.86 EUR.
Is UNH stock undervalued or overvalued?
Compared with the current market price of 312.6 EUR, the stock appears Undervalued by 29% .